Veracyte, Inc. Common Stock (NASDAQ: VCYT) last traded at $42.31, up 1.24% on the session. The quote above updates while this page is open; the figures below are drawn from Veracyte, Inc. Common Stock’s own filings and are restated only when a new one is published.
Veracyte, Inc. Common Stock trades on NASDAQ under the ticker VCYT. Its market capitalisation is $3.40 billion.
Valuation measures for Veracyte, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $3.40B |
|---|---|
| Enterprise value | $3.20B |
| P/E ratio | 30.22 |
| Price / sales | 6.05 |
| Price / book | 2.45 |
| Beta | 1.45 |
Trailing-twelve-month figures tagged in Veracyte, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $561.90M |
|---|---|
| Net income (TTM) | $114.48M |
| EPS (TTM) | $1.40 |
| Gross margin | 71.71% |
| Operating margin | 18.82% |
| Return on equity | 8.25% |
| Cash | $299.52M |
Range and volume for VCYT over the past 52 weeks.
| 52-week high | $60.91 |
|---|---|
| 52-week low | $28.25 |
| Volume | 954.6K |
| Average volume | 1.34M |
| Previous close | $41.79 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.